https://www.selleckchem.com/pr....oducts/Tanshinone-I.
Switching from standard to extended half-life FVIII prophylaxis resulted in increased mean dosing, while the mean number of weekly prophylactic injections (2.6±0.5 vs 1.8±0.3) decreased. Following rFVIIIFc initiation, a non-significant increase in median MPR occurred and the self-reported VERITAS-Pro questionnaire demonstrated improved adherence to rFVIIIFc prophylaxis. Comparing adherent and non-adherent patients revealed age as the only factor likely to impact adherence (p=.07). Our patient cohort exhibited high adherence levels
Like
Comment
Share
